These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 16568721

  • 1. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.
    Wang SN, Chung SC, Tsai KB, Chai CY, Chang WT, Kuo KK, Chen JS, Lee KT.
    Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721
    [Abstract] [Full Text] [Related]

  • 2. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P, Marchegiani C, Capella C, Sessa F.
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
    Takashima M, Ueki T, Nagai E, Yao T, Yamaguchi K, Tanaka M, Tsuneyoshi M.
    Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
    Shrestha ML, Miyake H, Kikutsuji T, Tashiro S.
    J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
    [Abstract] [Full Text] [Related]

  • 12. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
    Nagata S, Ajioka Y, Nishikura K, Watanabe G, Inoue T, Yamaguchi K, Watanabe H, Tanaka M, Tsuneyoshi M.
    Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
    Rajala RV, Radhi JM, Kakkar R, Datla RS, Sharma RK.
    Cancer; 2000 May 01; 88(9):1992-9. PubMed ID: 10813869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I, Villaseca M, Araya JC, Roa J, de Aretxabala X, Fuentealba P, Melo A.
    Cancer Epidemiol Biomarkers Prev; 1997 Jul 01; 6(7):547-50. PubMed ID: 9232344
    [Abstract] [Full Text] [Related]

  • 18. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
    Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y.
    J Pathol; 1993 May 01; 170(1):67-72. PubMed ID: 8100854
    [Abstract] [Full Text] [Related]

  • 19. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Tomoyose T, Takano H, Funaki K, Fukuyama H, Takahashi T, Sakoda S.
    J Oral Pathol Med; 2005 Nov 01; 34(10):602-7. PubMed ID: 16202080
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.